|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:988-993
© 2006 The American Association for Thoracic Surgery
General Thoracic Surgery |
Division of General Thoracic Surgery, Department of Surgery (E1), Osaka University Graduate School of Medicine, Osaka, Japan
Received for publication October 12, 2005; revisions received December 11, 2005; accepted for publication December 16, 2005. * Address for reprints: Masayoshi Inoue, MD, PhD, 2-2 Yamadaoka Suita-city, Osaka 565-0871, Japan (Email: masa{at}surg1.med.osaka-u.ac.jp).
OBJECTIVE: The number of surgical interventions for small-sized lung cancer has increased with the development of computed tomography. We attempted to identify clinicopathologic characteristics of peripheral, small-sized, nonsmall cell lung cancer to show the limitation of partial resection or segmentectomy.
METHODS: A retrospective analysis of 143 patients who underwent a complete resection for a peripheral nonsmall cell lung cancer of 2 cm or less in diameter was performed. The relationships between nodal involvement and other clinical factors were also assessed in patients who underwent a lobectomy plus node dissection.
RESULTS: The overall 5-year survival rate was 88.1%. The 5-year survival rate was 100% for patients with a tumor of 1.5 cm or less. Survival for patients with adenocarcinoma histology was significantly better than for those with nonadenocarcinoma histology (P = .03). The 5-year survival rate for patients without lymph node metastases was 91.6%, whereas it was 62.5% for those with nodal involvement (P < .01). Increase of prethoracotomy serum carcinoembryonic antigen level was an independent predictor of a poor prognosis. Lymph node metastasis was significantly increased in those with pleural invasion by the primary lesion and increased serum carcinoembryonic antigen level. Fourteen (16.9%) of 83 patients with a tumor diameter of larger than 1.5 cm had nodal metastasis.
CONCLUSIONS: Nodal involvement should be considered in patients with nonsmall cell lung cancer of 2 cm or less in diameter who show pleural invasion or an increased carcinoembryonic antigen level. A lobectomy with node dissection is recommended for patients with a tumor larger than 1.5 cm, suspected pleural invasion, or prethoracotomy carcinoembryonic antigen level increase.
This article has been cited by other articles:
![]() |
A. Yilmaz, S. S. Duyar, E. Cakir, E. Aydin, F. Demirag, J. Karakaya, U. Yazici, and Y. Erdogan Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer Eur J Cardiothorac Surg, September 1, 2011; 40(3): 664 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Igai, N. Matsuura, S. Tarumi, S. S. Chang, N. Misaki, T. Go, S. Ishikawa, and H. Yokomise Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors Eur J Cardiothorac Surg, June 1, 2011; 39(6): 963 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, O. Honda, N. Tomiyama, M. Minami, N. Sawabata, Y. Kadota, Y. Shintani, Y. Ohno, and M. Okumura Risk of Pleural Recurrence After Computed Tomographic-Guided Percutaneous Needle Biopsy in Stage I Lung Cancer Patients Ann. Thorac. Surg., April 1, 2011; 91(4): 1066 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, M. Minami, N. Sawabata, T. Utsumi, Y. Kadota, N. Shigemura, and M. Okumura Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer Eur J Cardiothorac Surg, June 1, 2010; 37(6): 1445 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kawachi, Y. Nakazato, H. Takei, Y. Koshi-ishi, and T. Goya Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage? Interact CardioVasc Thorac Surg, August 1, 2009; 9(2): 199 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Whitson, S. S. Groth, S. J. Duval, S. J. Swanson, and M. A. Maddaus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review of the Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Approaches to Lobectomy Ann. Thorac. Surg., December 1, 2008; 86(6): 2008 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, T. Takakuwa, M. Minami, H. Shiono, T. Utsumi, Y. Kadota, T. Nasu, K. Aozasa, and M. Okumura Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 830 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. I. Ou, J. A. Zell, A. Ziogas, and H. Anton-Culver Prognostic Significance of the Non-Size-Based AJCC T2 Descriptors: Visceral Pleura Invasion, Hilar Atelectasis, or Obstructive Pneumonitis in Stage IB Non-small Cell Lung Cancer Is Dependent on Tumor Size Chest, March 1, 2008; 133(3): 662 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Hung, C.-Y. Wang, M.-H. Huang, B.-S. Huang, W.-H. Hsu, and Y.-C. Wu Prognostic factors in resected stage I non small cell lung cancer with a diameter of 3 cm or less: Visceral pleural invasion did not influence overall and disease-free survival J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 638 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Putnam Jr Invited commentary Ann. Thorac. Surg., February 1, 2007; 83(2): 424 - 424. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |